China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Role of TREM2 in Regulating Microglial Transition and Its Implications in Parkinson's Disease Pathogenesis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132605
Registration Time: 2026/09/16
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=304617
Published by HT Digital Content Services with permission from Health Daily Digest....